Annual Current Liabilities
$121.86 M
+$20.91 M+20.72%
December 31, 2022
Summary
- As of February 10, 2025, IMGN annual total current liabilities is $121.86 million, with the most recent change of +$20.91 million (+20.72%) on December 31, 2022.
- During the last 3 years, IMGN annual current liabilities has risen by +$44.45 million (+57.42%).
Performance
IMGN Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$134.66 M
+$40.96 M+43.71%
September 30, 2023
Summary
- As of February 10, 2025, IMGN quarterly total current liabilities is $134.66 million, with the most recent change of +$40.96 million (+43.71%) on September 30, 2023.
- Over the past year, IMGN quarterly current liabilities has increased by +$31.02 million (+29.93%).
Performance
IMGN Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
IMGN Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +20.7% | +29.9% |
3 y3 years | +57.4% | +34.9% |
5 y5 years | +118.5% | +91.4% |
IMGN Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | -17.2% | at high | -37.5% |
5 y | 5-year | -0.4% | -36.5% | at high | -42.5% |
alltime | all time | -0.4% | -98.9% | at high | -99.0% |
ImmunoGen Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2023 | - | $134.66 M(+43.7%) |
Jun 2023 | - | $93.70 M(-7.8%) |
Mar 2023 | - | $101.63 M(-16.6%) |
Dec 2022 | $121.86 M(+20.7%) | $121.86 M(+17.6%) |
Sep 2022 | - | $103.64 M(+19.0%) |
Jun 2022 | - | $87.07 M(+3.5%) |
Mar 2022 | - | $84.12 M(-16.7%) |
Dec 2021 | $100.94 M(-17.5%) | $100.94 M(-9.7%) |
Sep 2021 | - | $111.78 M(-7.1%) |
Jun 2021 | - | $120.32 M(-10.4%) |
Mar 2021 | - | $134.35 M(+9.8%) |
Dec 2020 | $122.32 M(+58.0%) | $122.32 M(+22.5%) |
Sep 2020 | - | $99.82 M(+9.8%) |
Jun 2020 | - | $90.88 M(+6.3%) |
Mar 2020 | - | $85.51 M(+10.5%) |
Dec 2019 | $77.41 M(+9.6%) | $77.41 M(-12.2%) |
Sep 2019 | - | $88.17 M(+18.2%) |
Jun 2019 | - | $74.62 M(+21.5%) |
Mar 2019 | - | $61.43 M(-13.1%) |
Dec 2018 | $70.66 M(+26.7%) | $70.66 M(+0.4%) |
Sep 2018 | - | $70.37 M(+11.1%) |
Jun 2018 | - | $63.35 M(-4.3%) |
Mar 2018 | - | $66.23 M(+18.8%) |
Dec 2017 | $55.77 M(-0.0%) | $55.77 M(-24.3%) |
Sep 2017 | - | $73.66 M(+9.4%) |
Jun 2017 | - | $67.35 M(+66.8%) |
Mar 2017 | - | $40.37 M(-28.2%) |
Dec 2016 | $55.78 M(-7.7%) | - |
Sep 2016 | - | $56.23 M(-7.0%) |
Jun 2016 | $60.44 M(+74.4%) | $60.44 M(+51.7%) |
Mar 2016 | - | $39.83 M(-9.3%) |
Dec 2015 | - | $43.90 M(+22.1%) |
Sep 2015 | - | $35.95 M(+3.7%) |
Jun 2015 | $34.65 M(+63.0%) | $34.65 M(+51.9%) |
Mar 2015 | - | $22.81 M(+16.1%) |
Dec 2014 | - | $19.64 M(-50.6%) |
Sep 2014 | - | $39.77 M(+87.1%) |
Jun 2014 | $21.25 M(+10.9%) | $21.25 M(+0.3%) |
Mar 2014 | - | $21.20 M(+20.2%) |
Dec 2013 | - | $17.63 M(+6.6%) |
Sep 2013 | - | $16.54 M(-13.7%) |
Jun 2013 | $19.17 M(+18.0%) | $19.17 M(+14.0%) |
Mar 2013 | - | $16.81 M(+14.9%) |
Dec 2012 | - | $14.63 M(-5.2%) |
Sep 2012 | - | $15.43 M(-5.1%) |
Jun 2012 | $16.25 M(+11.6%) | $16.25 M(+9.8%) |
Mar 2012 | - | $14.80 M(+27.3%) |
Dec 2011 | - | $11.62 M(-12.1%) |
Sep 2011 | - | $13.22 M(-9.2%) |
Jun 2011 | $14.57 M(+5.4%) | $14.57 M(+8.9%) |
Mar 2011 | - | $13.37 M(+24.5%) |
Dec 2010 | - | $10.74 M(+10.6%) |
Sep 2010 | - | $9.71 M(-29.8%) |
Jun 2010 | $13.82 M(+24.2%) | $13.82 M(+21.5%) |
Mar 2010 | - | $11.38 M(-1.7%) |
Dec 2009 | - | $11.57 M(+16.4%) |
Sep 2009 | - | $9.94 M(-10.7%) |
Jun 2009 | $11.13 M(+7.1%) | $11.13 M(-6.0%) |
Mar 2009 | - | $11.84 M(-8.6%) |
Dec 2008 | - | $12.95 M(+27.5%) |
Sep 2008 | - | $10.15 M(-2.2%) |
Jun 2008 | $10.39 M(-27.3%) | $10.39 M(-50.9%) |
Mar 2008 | - | $21.15 M(+58.2%) |
Dec 2007 | - | $13.36 M(+5.0%) |
Sep 2007 | - | $12.73 M(-10.9%) |
Jun 2007 | $14.29 M | $14.29 M(-0.4%) |
Mar 2007 | - | $14.35 M(+12.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2006 | - | $12.81 M(+3.6%) |
Sep 2006 | - | $12.36 M(+15.3%) |
Jun 2006 | $10.72 M(+16.2%) | $10.72 M(-14.8%) |
Mar 2006 | - | $12.58 M(+14.7%) |
Dec 2005 | - | $10.97 M(+16.2%) |
Sep 2005 | - | $9.44 M(+2.3%) |
Jun 2005 | $9.23 M(-18.2%) | $9.23 M(-18.6%) |
Mar 2005 | - | $11.33 M(+30.4%) |
Dec 2004 | - | $8.69 M(-16.3%) |
Sep 2004 | - | $10.38 M(-8.0%) |
Jun 2004 | $11.29 M(+94.2%) | $11.29 M(-21.1%) |
Mar 2004 | - | $14.31 M(+33.1%) |
Dec 2003 | - | $10.75 M(+24.4%) |
Sep 2003 | - | $8.64 M(+48.7%) |
Jun 2003 | $5.81 M(-10.7%) | $5.81 M(-12.7%) |
Mar 2003 | - | $6.66 M(-20.8%) |
Dec 2002 | - | $8.40 M(+17.3%) |
Sep 2002 | - | $7.16 M(+10.1%) |
Jun 2002 | $6.50 M(+21.3%) | $6.50 M(-7.1%) |
Mar 2002 | - | $7.00 M(-22.7%) |
Dec 2001 | - | $9.06 M(+68.5%) |
Sep 2001 | - | $5.37 M(+0.3%) |
Jun 2001 | $5.36 M(+117.2%) | $5.36 M(+54.9%) |
Mar 2001 | - | $3.46 M(+32.6%) |
Dec 2000 | - | $2.61 M(-33.0%) |
Sep 2000 | - | $3.89 M(+57.7%) |
Jun 2000 | $2.47 M(+37.1%) | $2.47 M(+58.3%) |
Mar 2000 | - | $1.56 M(-2.5%) |
Dec 1999 | - | $1.60 M(-5.9%) |
Sep 1999 | - | $1.70 M(-5.6%) |
Jun 1999 | $1.80 M(+20.0%) | $1.80 M(+28.6%) |
Mar 1999 | - | $1.40 M(+7.7%) |
Dec 1998 | - | $1.30 M(0.0%) |
Sep 1998 | - | $1.30 M(-13.3%) |
Jun 1998 | $1.50 M(-16.7%) | $1.50 M(+15.4%) |
Mar 1998 | - | $1.30 M(-23.5%) |
Dec 1997 | - | $1.70 M(+13.3%) |
Sep 1997 | - | $1.50 M(-16.7%) |
Jun 1997 | $1.80 M(-5.3%) | $1.80 M(-5.3%) |
Mar 1997 | - | $1.90 M(-17.4%) |
Dec 1996 | - | $2.30 M(+9.5%) |
Sep 1996 | - | $2.10 M(+10.5%) |
Jun 1996 | $1.90 M(-57.8%) | $1.90 M(-47.2%) |
Mar 1996 | - | $3.60 M(-2.7%) |
Dec 1995 | - | $3.70 M(-17.8%) |
Sep 1995 | - | $4.50 M(0.0%) |
Jun 1995 | $4.50 M(-8.2%) | $4.50 M(+9.8%) |
Mar 1995 | - | $4.10 M(+2.5%) |
Sep 1994 | - | $4.00 M(-18.4%) |
Jun 1994 | $4.90 M(+4.3%) | $4.90 M(-19.7%) |
Mar 1994 | - | $6.10 M(+64.9%) |
Dec 1993 | - | $3.70 M(+23.3%) |
Sep 1993 | - | $3.00 M(-36.2%) |
Jun 1993 | $4.70 M(+95.8%) | $4.70 M(+46.9%) |
Mar 1993 | - | $3.20 M(+39.1%) |
Dec 1992 | - | $2.30 M(+27.8%) |
Sep 1992 | - | $1.80 M(-25.0%) |
Jun 1992 | $2.40 M(+33.3%) | $2.40 M(+26.3%) |
Mar 1992 | - | $1.90 M(+11.8%) |
Sep 1991 | - | $1.70 M(-5.6%) |
Jun 1991 | $1.80 M(-18.2%) | $1.80 M(-10.0%) |
Mar 1991 | - | $2.00 M(+11.1%) |
Dec 1990 | - | $1.80 M(-5.3%) |
Sep 1990 | - | $1.90 M(-13.6%) |
Jun 1990 | $2.20 M(+69.2%) | $2.20 M(+22.2%) |
Mar 1990 | - | $1.80 M(+20.0%) |
Sep 1989 | - | $1.50 M(+15.4%) |
Jun 1989 | $1.30 M | $1.30 M |
FAQ
- What is ImmunoGen annual total current liabilities?
- What is the all time high annual current liabilities for ImmunoGen?
- What is ImmunoGen annual current liabilities year-on-year change?
- What is ImmunoGen quarterly total current liabilities?
- What is the all time high quarterly current liabilities for ImmunoGen?
- What is ImmunoGen quarterly current liabilities year-on-year change?
What is ImmunoGen annual total current liabilities?
The current annual current liabilities of IMGN is $121.86 M
What is the all time high annual current liabilities for ImmunoGen?
ImmunoGen all-time high annual total current liabilities is $122.32 M
What is ImmunoGen annual current liabilities year-on-year change?
Over the past year, IMGN annual total current liabilities has changed by +$20.91 M (+20.72%)
What is ImmunoGen quarterly total current liabilities?
The current quarterly current liabilities of IMGN is $134.66 M
What is the all time high quarterly current liabilities for ImmunoGen?
ImmunoGen all-time high quarterly total current liabilities is $134.66 M
What is ImmunoGen quarterly current liabilities year-on-year change?
Over the past year, IMGN quarterly total current liabilities has changed by +$31.02 M (+29.93%)